IP Library › Assignment 065102/0208
Patent Assignment
Reel/Frame 065102/0208

Assignment of Assignor's Interest

Recorded: 2023-10-02 Pages: 8
Assignors
WATSON, PAUL STEVEN
Executed: 2017-08-23
BERNER, BRET
Executed: 2017-08-22
REID, JOHN GREGORY
Executed: 2017-08-23
WANG, JIAN
Executed: 2017-08-23
Assignee
SAGE THERAPEUTICS, INC.
215 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (2)
A Crystalline 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid
Application: 17/396,464 →
Publication: US 2022/0169674
Crystalline 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid
Application: 18/455,324 →
Publication: US 2023/0399357
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 2, 2023
From: KANES, STEPHEN J.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065098/0615 →
Assignment of Assignor's Interest Oct 2, 2023
From: DOHERTY, JAMES J.
To: SAGE THERAPEUTICS, INC.
Reel/Frame 065098/0654 →
Change of Name May 13, 2026
From: SAGE THERAPEUTICS, INC.
To: SAGE THERAPEUTICS, LLC
Reel/Frame 075610/0448 →